REYON Pharmaceutical Co., Ltd. акциялары

Operating both domestically in South Korea and across international markets, REYON Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's diverse range of offerings addresses various therapeutic areas, including adrenal corticosteroids; angiotensin II receptor antagonists; anticholinergics; antiemetics; antihypertensives; anti-inflammatory enzymes; lipid-lowering, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer treatments; antispasmodics; benign prostatic hypertrophy therapies; cough and cold remedies; cardiac stimulants; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis medications; local anesthetics; migraine drugs; a variety of cardiovascular system drugs; medications for neuromuscular disorders; nootropics and neurotonics; non-steroidal anti-inflammatory drugs (NSAIDs); respiratory stimulants; skeletal muscle relaxants; and vasodilators. Established in 1955, REYON Pharmaceutical Co., Ltd. maintains its corporate headquarters in Seoul, South Korea.